COCP vs NVR · rev $105.0K vs P/E 15, rev $4.21B
Cocrystal Pharma Inc (COCP) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
COCP currently screens at market cap $13.3M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the COCP and NVR stock pages for the full models.
Not investment advice.